Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial

References

• Rubino MS, Abdel-Misih RZ, Bennett JJ, et al. Peritoneal surface malignancies and regional treatment: a review of the literature. Surg Oncol. 2012;21:87–94.
   PubMed Web of Science ®Google Scholar
• Chua TC, Yan TD, Saxena A, et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900–907.
   PubMed Web of Science ®Google Scholar
• Malfroy S, Wallet F, Maucort-Boulch D, et al. Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score. Surg Oncol. 2016;25:6–15.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Corbella D, Finazzi P, et al. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82:310–319.
   PubMed Web of Science ®Google Scholar
• Ceresoli M, Coccolini F, Ansaloni L. HIPEC and nephrotoxicity: a cisplatin induced effect?. Eur J Surg Oncol. 2016;42:909–910.
   PubMed Web of Science ®Google Scholar
• Meersch M, Schmidt C, Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125:1223–1232.
   PubMed Web of Science ®Google Scholar
• Lambert E, Schlaich M. The role of renal sympathetic nerves in ischemia reperfusion injury. Auton Neurosci. 2017;204:105–111.
   PubMed Web of Science ®Google Scholar
• Prowle JR, Bellomo R. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35:64–74.
   PubMed Web of Science ®Google Scholar
• Arjona-Sanchez A, Cadenas-Febres A, Cabrera-Bermon J, et al. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42:869–876.
   PubMed Web of Science ®Google Scholar
• Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442–448.
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–3370.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Yared JP, Worley S, et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64:239–246.
   PubMed Web of Science ®Google Scholar
• Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249:851–858.
   PubMed Web of Science ®Google Scholar
• Keating GM. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015;75:1119–1130.
   PubMed Web of Science ®Google Scholar
• Jiang L, Hu M, Lu Y, et al. The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis. J Clin Anesth. 2017;40:25–32.
   PubMed Web of Science ®Google Scholar
• Cai Y, Xu H, Yan J, et al. Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. Mol Med Rep. 2014;9:1542–1550.
   PubMed Web of Science ®Google Scholar
• Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.
   PubMed Web of Science ®Google Scholar
• Kocoglu H, Ozturk H, Ozturk H, et al. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail. 2009;31:70–74.
   PubMed Web of Science ®Google Scholar
• Hsing CH, Lin CF, So E, et al. α 2 -Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Renal Physiol. 2012;303:F1443–F1453.
   PubMed Web of Science ®Google Scholar
• Xu H, Aibiki M, Seki K, et al. Effects of dexmedetomidine, an alpha2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits. J Auton Nerv Syst. 1998;71:48–54.
   PubMedGoogle Scholar
• Gellai M, Ruffolo RR. Renal effects of selective alpha-1 and alpha-2 adrenoceptor agonists in conscious, normotensive rats. J Pharmacol Exp Ther. 1987;240:723–728.
   PubMed Web of Science ®Google Scholar
• Taoda M, Adachi YU, Uchihashi Y, et al. Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor. Neurochem Int. 2001;38:317–322.
   PubMed Web of Science ®Google Scholar
• Cho JS, Shim JK, Soh S, et al. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693–700.
   PubMed Web of Science ®Google Scholar
• Zhai M, Kang F, Han M, et al. The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: a double-blind randomized controlled trial. J Clin Anesth. 2017;40:33–38.
   PubMed Web of Science ®Google Scholar
• Jo YY, Kim JY, Lee JY, et al. The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial. Medicine. 2017;96:e7480.
   PubMed Web of Science ®Google Scholar
• Bayram A, Esmaoglu A, Akin A, et al. The effects of intraoperative infusion of dexmedetomidine on early renal function after percutaneous nephrolithotomy. Acta Anaesthesiol Scand. 2011;55:539–544.
   PubMed Web of Science ®Google Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–735.
   PubMed Web of Science ®Google Scholar
• Park EJ, Baik SH, Hur H, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: clinical outcomes at 2 tertiary referral centers in Korea. Medicine. 2017;96:e6632.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Lameire N. KDIGO AKI Guideline Work Group, Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.
   PubMed Web of Science ®Google Scholar
• Tan GHC, Shannon NB, Chia CS, et al. Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Hyperthermia. 2018;34:595–600.
   PubMed Web of Science ®Google Scholar
• Liang H, Liu HZ, Wang HB, et al. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Inflamm Res. 2017;66:399–411.
   PubMed Web of Science ®Google Scholar
• Vaira M, Barone R, Aghemo B, et al. Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study. Minerva Med. 2001;92:207–211.
   PubMedGoogle Scholar
• Yamamoto Y, Watanabe K, Tsukiyama I, et al. Hydration with 15 mEq magnesium is effective at reducing the risk for cisplatin-induced nephrotoxicity in patients receiving cisplatin (≥ 50 mg/m2) combination chemotherapy. Anticancer Res. 2016;36:1873–1877.
   PubMed Web of Science ®Google Scholar
• Zimpfer M, Khosropour R, Lackner F. Effect of dobutamine on cardiac function in man: reciprocal roles of heart rate and ventricular stroke volume. Crit Care Med. 1982;10:367–370.
   PubMed Web of Science ®Google Scholar
• Morelli A, Singer M, Ranieri VM, et al. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study. Intensive Care Med. 2016;42:1528–1534.
   PubMed Web of Science ®Google Scholar
• Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth. 2002;89:622–632.
   PubMed Web of Science ®Google Scholar
• Herrera-Gutierrez ME, Seller-Perez G, Banderas-Bravo E, et al. Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med. 2007;33:1900–1906.
   PubMed Web of Science ®Google Scholar
• van Meer L, Moerland M, Cohen AF, et al. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol. 2014;77:947–957.
   PubMed Web of Science ®Google Scholar
• Vlaeminck-Guillem V, Bienvenu J, Isaac S, et al. Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies). Ann Surg Oncol. 2013;20:2655–2662.
   PubMed Web of Science ®Google Scholar